Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional studyE Tartour, J Y Blay, T Dorval, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 familyF A Montero-Julian, H Brailly, C Sautès, et al.
The Journal of Urology|February 25, 1998
p53 status does not predict initial clinical response to bacillus Calmette-Guerin intravesical therapy in T1 bladder tumorsF Pages, T A Flam, A Vieillefond, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 1996
N-MYC amplification, loss of heterozygosity on the short arm of chromosome 1 and DNA ploidy in retinoblastomaF Doz, M Peter, G Schleiermacher, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2014
Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma?M Ben Arush, V Minard-Colin, V Mosseri, et al.
Breast (Edinburgh, Scotland)|January 7, 2014
Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgeryE Guillot, C Vaysse, J Goetgeluck, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Société Française d'Oncologie PédiatriqueF Doz, S Neuenschwander, E Bouffet, et al.
Cancer Research|August 14, 1999
Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude miceE Tartour, F Fossiez, I Joyeux, et al.
British Journal of Cancer|June 21, 2007
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplificationG Schleiermacher, J Michon, I Huon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2005
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology StudyV Oyharcabal-Bourden, C Kalifa, J C Gentet, et al.
Pageof 9